Loading...
ROCO
6518
Market cap33mUSD
Jul 09, Last price  
32.00TWD
1D
-1.54%
1Q
21.67%
Jan 2017
60.97%
IPO
-15.30%
Name

Concord Medical Co Ltd

Chart & Performance

D1W1MN
ROCO:6518 chart
P/E
15.70
P/S
1.11
EPS
2.04
Div Yield, %
3.44%
Shrs. gr., 5y
6.07%
Rev. gr., 5y
3.56%
Revenues
964m
+8.37%
763,766,000809,704,000738,988,000889,205,000833,202,000889,845,000964,351,000
Net income
68m
+37.04%
31,379,00019,773,00034,397,00050,656,00042,744,00049,570,00067,932,000
CFO
157m
+5.65%
131,059,00084,065,000137,424,000154,561,000113,226,000148,833,000157,238,000
Dividend
Apr 10, 20251.1 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Concord Medical Co., Ltd. delivers extensive support services for hospital administration across Taiwan, Myanmar, and China. The company's portfolio of services includes critical medical management assistance, covering professional training for healthcare staff, the provision of nursing personnel, and general operational guidance. Additionally, Concord Medical offers comprehensive procurement solutions, sourcing a broad spectrum of items such as medical devices, pharmaceuticals, general medical supplies and consumables, as well as specialized inspection equipment and laboratory reagents. Expanding its ventures, the firm also develops and markets its own proprietary brands, which feature aesthetic healthcare products, nutritional supplements, and prepared traditional Chinese medicines. Furthermore, Concord Medical is actively involved in the strategic planning and sales of medical equipment, alongside offering medical apparatus leasing services. Concord Medical Co., Ltd. was established in 2009 and is headquartered in New Taipei City, Taiwan.
IPO date
May 13, 2015
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT